ask="N/A"
ask_size="N/A"
average_daily_volume="19705"
bid="0.0002"
bid_size="250000"
book_value="0.0000"
change="-0.0063"
change_from_200_day_moving_average="-0.0680"
change_from_50_day_moving_average="-0.0896"
change_from_52_week_high="-0.7946"
change_From_52_week_low="0.0654"
change_in_percent="-5.6401%"
close="0.1054"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="N/A"
ebitda="0.00"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="N/A"
ex_dividend_date="N/A"
float_shares="N/A"
high="0.1198"
high_52_weeks="0.9000"
last_trade_date="3/6/2017"
last_trade_price="0.1054"
last_trade_size="100"
last_trade_time="1:31pm"
low="0.1001"
low_52_weeks="0.0400"
market_capitalization="N/A"
moving_average_200_day="0.1734"
moving_average_50_day="0.1950"
name="Galectin Therapeutics Inc."
notes="N/A"
one_year_target_price="N/A"
open="0.1172"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-39.2178%"
percent_change_from_50_day_moving_average="-45.9487%"
percent_change_from_52_week_high="-88.2889%"
percent_change_from_52_week_low="+163.5000%"
previous_close="0.1117"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="N/A"
short_ratio="0.0000"
stock_exchange="NCM"
symbol="GALTW"
volume="15074"
weeks_range_52="0.0400 - 0.9000"
